Do you want to read an article? Please log in or register.
Effectiveness of Mepolizumab in Patients with OCS-Dependent Severe Asthma: A Real-World Study
Asthma
Related content
Asthma
Impact of Health Insurance Type on Access to Biologics and Systemic Corticosteroid Exposure in Patients With Severe Asthma: A Real-World Study From the Korean Severe Asthma Registry (KoSAR)
Allergy Asthma Immunol Res
Sohn KH, Lee SK, Lee HY, Kim SR, Lee SE, Kim JH, Song WJ, Kim SH, Korean Severe Asthma Registry (KoSAR) Investigators
doi: 10.4168/aair.2026.18.2.192
RECOMMENDED
Asthma
Real-World Effectiveness and Safety of Mepolizumab in Pediatric Severe Eosinophilic Asthma: A Multicenter Study
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Pediatr Pulmonol
Çevik NN, Ocak M, Kocatepe G, Teker NB, Kocacik Uygun DF, Serbes M, Ozcan D, Bingol A, Sekerel BE
doi: 10.1002/ppul.71466
Asthma
Real-World Effectiveness Following Benralizumab Use in Patients with Severe Eosinophilic Asthma in Romania: A Retrospective Cohort Study (BREEZE)
J Clin Med
Toma CL, Teodorescu G, Mihălţan FD, Frent S, Ali S, Trenchea M, Constantin AA
doi: 10.3390/jcm15020425
Asthma
Early and continued asthma control up to week 24 in patients with severe, uncontrolled asthma treated with tezepelumab: Initial results of the real-world ASCENT study
Respir Med
Milger K, Dorscheid D, Gessner C, Hilberg O, Llanos JP, Nåtman J, Urbanski H, Clarke DL, Emmanuel B, Stjepanovic N
doi: 10.1016/j.rmed.2026.109075
Asthma
Tezepelumab in Real-World U.S. Patients with Severe Asthma Across Phenotypes and Underrepresented Populations: The Phase 4 PASSAGE Study
Am J Respir Crit Care Med
Lugogo NL, Akuthota P, Sumino K, Burnette AF, Mathur SK, Lindsley AW, Llanos JP, Marchese C, Ambrose CS, Emmanuel B
doi: 10.1093/ajrccm/aamag225
Asthma
Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain
J Clin Med
García-Moguel I, Agüero Calvo J, Betancor Pérez D, Carretero Gracia JÁ, Díaz-Campos RM, Fernández Martínez de Septien C, Gómez-Bastero Fernández A, Hernández Galván Y, Lloret-Queraltó JA, Lluch Tortajada I, Malanda NM, Martín-García C, Martínez Mesa Á, Martínez-Moragon E, Medina Gallardo JF, Padilla-Galo A, Pérez Chica G, Plasencia García I, Prieto Montaño P, Puchaes Manchón C, Romero Ribate D, Valverde-Monge M, Zamarro Parra MS, Sanchez-Trincado JL, Nuevo J, Luzon E, Velasco-Garrido JL
doi: 10.3390/jcm15124564
AsthmaRespiratory Tract Infection
Dual Remission in Patients with Moderate-to-Severe Asthma and CRSwNP Treated with Dupilumab: A 24-Month Real-World Study
J Clin Med
Menzella F, Berti A, Cestaro W, Bosi A, Munari S, Gialdini F, Scandiuzzi Piovesan T, Cottini M, Lombardi C, Corsi L, De Corso E
doi: 10.3390/jcm15072787
Asthma
Real-World Response to Dupilumab as Add-on Therapy in Adults and Adolescents with Type 2 Severe Asthma: A Spanish Cohort Study
J Asthma Allergy
Montoro Ferrer A, Moro Moro MDM, Parra Borreguero FM, Moreno-Ancillo A, Extremera Ortega AM, Galindo-Bonilla PA, Jiménez Lara M, Bravo Nieto JM, Jiménez Arroyo M, Lemus Calderón JA, Espinosa de Los Monteros Garde MJ
doi: 10.2147/JAA.S582686
Respiratory Tract Infection
Mepolizumab effectiveness for patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in Italy (MEPOREAL): a real-life, multicentre, phase 4 trial
Lancet Respir Med
De Corso E, Ottaviano G, Seccia V, Pipolo C, Canevari FRM, Maggiore G, Cantone E, Pagella F, Anastasi F, Pasquini E, Torretta S, Garzaro M, Gallo S, Loperfido A, D'Ascanio L, Moffa A, Cavaliere C, Caruso M, Anzivino R, Fadda G, Passali FM, Iannuzzi L, Urbanelli A, Tomacelli GL, Poma S, Corbò M, Montuori C, D'Auria LM, Galli J, La Mantia I, ENT Biologic Italian study group (PolyData Forum)
doi: 10.1016/S2213-2600(26)00197-9